Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sanuwave Health Inc SNWV

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular... see more

Recent & Breaking News (OTCQB:SNWV)

SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)

GlobeNewswire April 10, 2024

SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer

GlobeNewswire April 1, 2024

SANUWAVE Announces Record Q4 and FY2023 Revenue

GlobeNewswire March 22, 2024

SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results

GlobeNewswire March 20, 2024

SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders

GlobeNewswire February 22, 2024

SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)

GlobeNewswire January 22, 2024

SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023

GlobeNewswire January 10, 2024

SANUWAVE Announces Q3 2023 Financial Results

GlobeNewswire November 10, 2023

SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results

GlobeNewswire November 8, 2023

SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023

GlobeNewswire October 10, 2023

SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company

GlobeNewswire August 23, 2023

SANUWAVE Announces Q2 2023 Financial Results

GlobeNewswire August 11, 2023

SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results

GlobeNewswire August 9, 2023

SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.

GlobeNewswire August 1, 2023

SANUWAVE Health Appoints Industry Veteran Andrew Walko as President

GlobeNewswire July 31, 2023

SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023

GlobeNewswire July 17, 2023

SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer

GlobeNewswire May 24, 2023

SANUWAVE Announces Q1 2023 Financial Results

GlobeNewswire May 12, 2023

SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9:00 AM to Provide a Financial and Business Update

GlobeNewswire May 11, 2023

SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference

GlobeNewswire April 27, 2023